Quadrant Private Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Quadrant Private Wealth Management's GILD Position: Q1 2026 in Review
Quadrant Private Wealth Management increased its Gilead Sciences (GILD) stake by 1.7% in Q1 2026, buying an estimated $6.72K and bringing the position to 2,802 shares worth $391K. The position accounts for 0.06% of the portfolio, ranked #208.
Quadrant Private Wealth Management first reported a position in GILD in Q1 2020 and has held it in 21 quarters since. The position peaked at $1.06M in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Quadrant Private Wealth Management held 2,802 shares of Gilead Sciences worth $391K as of Q1 2026.
- Quadrant Private Wealth Management bought 48 Gilead Sciences shares in Q1 2026, an estimated $6.72K.
- Gilead Sciences made up 0.06% of Quadrant Private Wealth Management's portfolio in Q1 2026, its #208 holding.
- Quadrant Private Wealth Management first reported a position in Gilead Sciences in Q1 2020 and has held it in 21 quarters since.
- Quadrant Private Wealth Management's Gilead Sciences position peaked at $1.06M in Q2 2020.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Quadrant Private Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.